TheEdgeResearch
Home / Stocks / GRVE

Groove Botanicals, Inc. (GRVE)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$244,537
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.16
52-Wk Range
0.004-0.07
CEO
Kent A. Rodriguez
Country
US
Currency
USD

Groove Botanicals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Minneapolis, MN, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $244,537. On trailing twelve-month figures it carries a trailing P/E of -0.71, a net margin of 0.0%. Its beta of -0.16 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.71
Price / Sales
0.00
Price / Book
-0.16
EV / EBITDA
-2.39
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
-123.1%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2012-09-25
Headquarters
Minneapolis, MN, US
About Groove Botanicals, Inc.

Groove Botanicals, Inc. is an enterprise primarily focused on innovating electric vehicle (EV) battery technologies. Established in 1991, the company previously operated under the name Avalon Oil & Gas, Inc., officially adopting its current designation in May 2018. Its corporate headquarters are located in Minneapolis, Minnesota.

Comparable companies

Groove Botanicals, Inc. is most often compared with the following Healthcare names:

AREVFCNNXFGBHPFINQDINSOLTHOLVTTFMGWFFSTSNVIVXF
More research on GRVE
GRVE technical analysis GRVE TheEdge Score Compare against peers
Open full interactive analysis & DCF →